Bayer Pharma AG

Essence of this Article

Low molecular weight heparin (LMWH) and unfractionated heparin (UFH) are currently recommended for the treatment of venous thromboembolism (VTE) in pregnant patients; however, LMWH is the preferred choice. The suggested treatment duration for anticoagulation in pregnant women with acute VTE is a minimum of 3 months, which includes at least 6 weeks postpartum. The optimal duration of treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) during and after pregnancy has not been studied in randomized controlled trials.

Treatment of deep vein thrombosis and pulmonary embolism in pregnancy

The optimal duration of treatment of DVT and PE during and after pregnancy has not been studied in randomized controlled trials.

LMWH and UFH are currently recommended for the treatment of VTE in pregnant patients;267 however, LMWH is the preferred choice.271 The suggested treatment duration for anticoagulation in pregnant women with acute VTE is a minimum of 3 months, which includes at least 6 weeks postpartum.267

Recommendations for the prevention of VTE in pregnancy are covered by guidelines.


Where to next?